More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. Shareholder Letter

Medical Marijuana, Inc. Shareholder Letter

by adminAdrianRamirez | Jun 27, 2019 | Company News

June 27, 2019 Dear Shareholders: We write to update on the state of our company, Medical Marijuana, Inc.  Our organization has grown tremendously in 2017 and 2018 and we believe the company is on course to achieve new heights in 2019. Our slogan, “A Company of...
Dixie Botanicals®, Subsidiary of Medical Marijuana, Inc., Announces Partnership with Surface Products Corp. To Sell Fitness-Focused CBD-Infused Sunscreen

Dixie Botanicals®, Subsidiary of Medical Marijuana, Inc., Announces Partnership with Surface Products Corp. To Sell Fitness-Focused CBD-Infused Sunscreen

by adminAdrianRamirez | Jun 21, 2019 | Dixie Botanicals, Press Releases

SAN DIEGO, June 21, 2019 — Medical Marijuana, Inc. (MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply...
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Third Series of Cannabinoid Medicine Courses in São Paulo

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Third Series of Cannabinoid Medicine Courses in São Paulo

by adminAdrianRamirez | Jun 18, 2019 | HempMeds Brasil, Press Releases

SAN DIEGO, June 18, 2019 — Medical Marijuana, Inc. (OTC:MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply...
Forbes, Fox Business, U.S. News & World Report Among Media Outlets Featuring Medical Marijuana, Inc.

Forbes, Fox Business, U.S. News & World Report Among Media Outlets Featuring Medical Marijuana, Inc.

by adminAdrianRamirez | Jun 17, 2019 | Kannaway, Media Coverage

CBD and potential FDA regulation, CBD in Europe, and CBD disrupting the direct selling market lead our company headlines this week. Medical Marijuana, Inc. and our family of companies were at the center of numerous news stories this week as our efforts to expand...
Forbes, Fox Business, U.S. News & World Report Among Media Outlets Featuring Medical Marijuana, Inc.

FORBES, FOX BUSINESS, U.S. NEWS UND WORLD REPORT UNTER DEN MEDIEN, DIE ÜBER MEDICAL MARIJUANA, INC. BERICHTEN

by adminAdrianRamirez | Jun 17, 2019 | Kannaway, Media Coverage

CBD UND EINE MÖGLICHE REGULIERUNG DER FDA, CBD IN EUROPA UND CBD, DIE DEN DIREKTVERTRIEBSMARKT STÖRT, FÜHREN DIESE WOCHE DIE SCHLAGZEILEN UNSERES UNTERNEHMENS AN. Medical Marijuana, Inc. und unsere Unternehmensfamilie standen im Mittelpunkt zahlreicher Nachrichten in...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.